Resistance to anti-IgM-induced apoptosis in a WEHI-231 subline is due to insufficient production of ceramide

European Journal of Immunology
A R GottschalkJ Quintans

Abstract

We describe the properties of a physiological cell death (PCD)-resistant subline of WEHI-231 generated from the PCD-susceptible WEHI-231.7 JM cell line maintained in our laboratory. The PCD-resistant WEHI-231.7 JMRE subline was uniquely resistant to anti-immunoglobulin (Ig)M-induced PCD but not to irradiation and etoposide. In these sublines, we compared the expression of genes implicated in regulating PCD. Northern analysis of c-myc, c-fos, egr-1, Fas, p53 and retinoblastoma revealed similar basal levels of expression in all sublines tested and comparable responses to anti-IgM treatment. Similarly, the expression of bcl-2, bcl-x, bax and IL-1 beta converting enzyme did not correlate with susceptibility to anti-IgM-induced PCD. Next, we systematically studied signal transduction events including: tyrosine phosphorylation, Ca++ flux, and ceramide production in the Jm and JMRE sublines. The tyrosine phosphorylation patterns and the Ca++ influx generated following sIgM engagement were very similar in the JM and JMRE sublines. In contrast, the generation of ceramide differed in the PCD-resistant and PCD-susceptible sublines. Ceramide is produced following cross-linking sIgM on WEHI-231.7 JM cells and causes PCD. Ceramide levels in ...Continue Reading

References

Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R TischN Hozumi
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J E McCormackG E Sonenshein
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·F van StraatenI M Verma
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·A R GottschalkJ Quintáns
Jan 1, 1993·The Journal of Experimental Medicine·E RouvierP Golstein
Jul 29, 1994·Biochemical and Biophysical Research Communications·J QuintansG Dawson
Nov 1, 1993·European Journal of Immunology·U HibnerP Sarthou
Aug 1, 1993·European Journal of Immunology·A R GottschalkJ Quintáns
Mar 19, 1993·Science·L M ObeidY A Hannun

❮ Previous
Next ❯

Citations

Mar 31, 2000·Journal of Neuroscience Research·R Goswami, G Dawson
Jun 1, 1996·Current Opinion in Immunology·T L Rothstein
Oct 15, 1998·Transplantation·E S Woodle, S Kulkarni
Feb 15, 1996·European Journal of Biochemistry·A J HaleG T Williams
Jun 11, 1999·Immunology and Cell Biology·D Watters
Mar 28, 1998·The Journal of Biological Chemistry·L GenestierN Bonnefoy-Bérard
Sep 26, 1997·The Journal of Biological Chemistry·A D TepperW J van Blitterswijk
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marco J HeroldIngolf Berberich
Jun 13, 1998·Progress in Lipid Research·L RiboniG Tettamanti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.